Salary and benefits will be commensurate with experience. Please send detailed resume with current and expected salary by clicking Apply Now
We are an equal opportunity employer and welcome applications from all qualified candidates. The information provided will be treated in strict confidence and used only for consideration of application for relevant/similar post(s) within the CK Hutchison Group of Companies. Applicants not having heard from us within four weeks from the date of this advertisement may consider their application unsuccessful. All personal data of unsuccessful applicants will be destroyed after the recruitment exercise when no longer required.
We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capability. As of 2020, we have an in-house scientific team of over 600 professionals, and a pipeline of 10 clinical stage drug candidates in clinical studies around the world.
We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes prescription drugs and consumer health products, as well as two of our marketed novel oncology products – ELUNATE® (fruquintinib capsules)and SULANDA® (surufatinib capsules) - in China. We are expanding the geographic scope of our commercial operations to include the U.S. and Europe.
HUTCHMED is listed on the Nasdaq Global Select Market and on the London Stock Exchange’s AIM market (Nasdaq/AIM : HCM).